Pediatr. pro Praxi, 2007; 3: 140-143

PUFA OMEGA-3 AND THEIR EFFECTS

doc. MUDr. Ludmila Vyhnánková CSc
ORL specialista, Praha

This article deals with PUFA OMEGA-3 polyunsaturated fatty acids. They are vital for a child’s development, a development of brain and retina. They have a good influence on functioning of the brain, process of learning and on memory, immune system, act in an anti-inflammatory way. It is important that they have a positive influence on cardiovascular system and metabolism. I mention conclusions of the clinical studies which monitor the action of PUFA OMEGA-3 on human organism. Haliborange are food supplements with fish oil, a high PUFA OMEGA-3 content and with vitamins A, D, E and C. Orange-flavoured syrup, little fish and chewy capsules are suitable for children over 3 years.

Keywords: PUFA OMEGA-3, fish oil, a child, central nervous system, immunity, Haliborange

Published: July 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vyhnánková L. PUFA OMEGA-3 AND THEIR EFFECTS. Pediatr. praxi. 2007;8(3):140-143.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Auestad N, Scott DT, Janowsky J, et al. Visual, cognitive, and language assessments at 39 months: A follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age, Pediatrics 2003, 112, 177. Go to original source... Go to PubMed...
    2. Balk EM, Liechtenstein AH et al. Effects of omega-3 fatty acids on serum markers of cardiovascular risk: A systematic review, Atherosclerosis, 2006, article in press. Go to original source... Go to PubMed...
    3. Connor DL, Hall R, Adamkin D et al. Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: A prospective, randomized controlled trial. Pediatrics 2001, 108, 359-371. Go to original source... Go to PubMed...
    4. Conner WE. Importace of n-3 fatty acids in health and disease, Am. J Clin Nutr. 2000, 71 (suppl): 171S-175S. Go to original source... Go to PubMed...
    5. Crawford MA, Harbige L S. N-3 fatty acids and the evolution of the brain. Pro. Clin. Biol. Res.,1988; 288: 335-354.
    6. Dunstan JA, Mori TA, Barden A. et al. Fish oil supplementation in pregnancy modifies neonatal alergen-specific immune response and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. J. Allergy Clin. Immunol, 2003, 12, 1178-1184. Go to original source... Go to PubMed...
    7. Fleith M, Clandinin M. Links Dietary PUFA for preterm and term infants: review of clinical studies, Crit. Rev. Food Sci Nutr. 2005, 45 (3), 205-229. Go to original source... Go to PubMed...
    8. Fronczak CM, Baron AE, Chase HP et al. In utero dietary exposures and risk of islet autoimmunity in children. Diabetes Care, 2003, 26: 3237-3242. Go to original source... Go to PubMed...
    9. Groh-Wargo S, Jacobs J, Auestad N et al. Body composition in preterm infants who are fed long-chain polyunsaturated fatty acids: A prospective, randomized, controlled trial pediatric research, Copyright 2005 International Pediatric Research Foundation. Go to original source...
    10. Helland I, Smith L, Saarem K et al. Maternal supplementation with very-long. Chain a-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age, Pediatrics 2003, 111, 39-44. Go to original source... Go to PubMed...
    11. Kirby A. The discovery centre report on the, ,the omega-3 vitamin classroom study.
    12. Mourek J a kolektiv, Mastné kyseliny Omega-3 - Zdraví a vývoj, Triton, Praha/Kroměříž 2007.
    13. Richardson AJ, Montgomery P. The Oxford Durham Study: A randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder, Pediatrics 2005, 115, 1360-1366. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.